Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors.
Effects of glycolytic inhibitor 2-deoxy-D-glucose (2-DG) on radiation damage were studied in a human glioma cell line (BMG-1), grown to confluence in monolayer. After irradiation (60Co-gamma-rays, 2 Gy) and incubation with low concentrations of 2-DG (0.5, 1.25 mM; 2-DG/glucose = 0.1, 0.25; 2 hr), in the absence or presence of respiratory inhibitor KCN (0.5-2 mM), cells were trypsinized and plated to assay radiation induced cytogenetic damage (micronuclei formation). The observations made were: (1) 2-DG and/or KCN treatments did not induce damage in unirradiated cells. (2) Either of these treatments did not increase radiation induced micronuclei formation. (3) Presence of 2-DG along with KCN (1,2 mM) significantly enhanced the radiation induced micronuclei formation. (4) Preliminary experiments by macrocolony assay showed that radiation induced cell death was also significantly increased by the combined treatment. These observations suggest that presence of clinically feasible, low concentrations of 2-DG (2-DG/glucose < 0.5) for short intervals of time after radiation could increase radiation damage in non-cycling, hypoxic tumour cells with impaired oxidative and increased glycolytic energy metabolism.
Kalia
V K
VK
Department of Biophysics, National Institute of Mental Health & Neurosciences, Bangalore, India.
D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D002470:Cell Survival / Q000187:drug effects; D017024:Chemotherapy, Adjuvant; D004249:DNA Damage / Q000187:drug effects; D004273:DNA, Neoplasm / Q000187:drug effects / Q000528:radiation effects; D003847:Deoxyglucose / Q000494:pharmacology* / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D011190:Potassium Cyanide / Q000494:pharmacology* / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D003847:Deoxyglucose; D011190:Potassium Cyanide